Cleantech innovation for CO2 capture moves forward through Heirloom Carbon Technologies
PCI, along with Columbia University and the University of British Columbia, recently completed a license agreement with Heirloom Carbon Technologies.
IBA partners with Penn Medicine to develop flash therapy
IBA Worldwide, a technology company that develops particle accelerator technology, partnered with a team of faculty from Radiation Oncology at Penn Medicine led by Dr. James Metz.
Jiren Narendra Parikh
Jiren’s career spanned over 30 years as an entrepreneur, C-level and Senior Executive and included founding, scaling and supporting technology businesses.
Vivodyne named #1 “Small but Mighty” Company
Launched in 2021, Vivodyne’s platform allows fully automated, complex studies at a far larger scale and lower cost than would be possible with manual experimentation.
Wellcome Leap Funds Penn to develop “on-demand” manufacturing technology for RNA-based vaccines
Penn Engineering secured a multi-million-dollar contract with Wellcome Leap under the organization’s $60 million RNA Readiness + Response (R3) program.
John Trojanowski, MD, PhD
John Q. Trojanowski, MD, PhD is remembered as a neuroscience pioneer.
Penn’s Gene Therapy Program signs manufacturing partnership with the Center for Breakthrough Medicines
The Center for Breakthrough Medicines and Penn’s Gene Therapy Program (GTP) entered into a multi-year collaboration focusing on the manufacturing and testing of modern gene therapy processes.
ŌNŌCOR launches ŌNŌ system
PCI startup ŌNŌCOR announced the first-in-human use of their ŌNŌ endovascular retrieval system for the removal of an intracardiac tumor.
Neuralert’s first product receives FDA Breakthrough Designation
Neuralert addresses the problem of late or undetected stroke in hospitalized patients.
Faculty Innovators are Celebrated
The 6th annual Celebration of Innovation returned in a hybrid format for 2021 with both attendees and award recipients participating in person and virtually.